FDA Brief

Warning letters Drugs

FDA warning letter to

Meamo

High riskIssued Nov 3, 2025Posted Nov 5, 2025Center for Drug Evaluation and Research (CDER)

Meamo's website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.

What happened

FDA reviewed www.meamoshop.com and found it offers unapproved and misbranded injectable botulinum toxin drug products for sale to U.S. consumers. FDA cited examples marketed as “X4 Wondertox 100U Set” and “Wondertox,” including a website claim for “Treatment of benign essential blepharspasm in adult patients.” FDA said there are no approved applications for these products.

What FDA found

  1. The website offers new drugs without FDA approval.

    FD&C Act sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  2. The drug labeling lacks adequate directions for safe use by a layperson.

    FD&C Act section 502(f)(1) [21 U.S.C. § 352(f)(1)]
  3. Offering these drugs for sale causes misbranded drugs to enter interstate commerce.

    FD&C Act section 301(a) [21 U.S.C. § 331(a)]
  4. The drugs are not exempt from adequate-directions requirements because they are not approved in the U.S.

    21 CFR 201.115(a)

What FDA wants

FDA requests that www.meamoshop.com stop offering unapproved and misbranded drugs for sale to U.S. consumers. The company must notify FDA in writing within 15 working days describing corrective steps, or explain the delay and completion time.

Who should pay attention

  • U.S. consumers buying injectable drugs online
  • online retailers and distributors of botulinum toxin products
  • importers and suppliers of unapproved drug products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk